SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-154375
Filing Date
2024-06-04
Accepted
2024-06-04 17:13:10
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 d828212ds3.htm S-3 325279
2 EX-4.6 d828212dex46.htm EX-4.6 316428
3 EX-4.8 d828212dex48.htm EX-4.8 96045
4 EX-4.9 d828212dex49.htm EX-4.9 97456
5 EX-4.10 d828212dex410.htm EX-4.10 85601
6 EX-5.1 d828212dex51.htm EX-5.1 23531
7 EX-23.1 d828212dex231.htm EX-23.1 1676
8 EX-23.2 d828212dex232.htm EX-23.2 1821
9 EX-FILING FEES d828212dexfilingfees.htm EX-FILING FEES 29951
10 GRAPHIC g828212g0530050624843.jpg GRAPHIC 1826
11 GRAPHIC g828212g0530051122033.jpg GRAPHIC 2345
12 GRAPHIC g828212g12y45.jpg GRAPHIC 28691
  Complete submission text file 0001193125-24-154375.txt   1024609
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279941 | Film No.: 241019323
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)